Changes of peripheral blood during the antiviral treatment with Peg-IFNα-2 a for patients with chronic hepatitis B and the relationship between the changes and effect
10.3760/cma.j.issn.1003-9279.2017.05.015
- VernacularTitle: 慢性乙型病毒性肝炎干扰素抗病毒治疗外周血的变化特征及与疗效关系
- Author:
Zhenzhen LI
1
;
Shuling WU
;
Lu ZHANG
;
Yao LU
;
Weihua CAO
;
Xingyue WANG
;
Chongping RAN
;
Tianlin QI
;
Hongxiao HAO
;
Ge SHEN
;
Hongyu LIU
;
Min CHANG
;
Leiping HU
;
Minghui LI
;
Yao XIE
Author Information
1. Second Division of Liver Disease, Liver Center of Beijing Ditan Hospital, Capital Medical University, Beijing, 10015, China
- Publication Type:Journal Article
- Keywords:
Hepatitis chronic B;
IFN;
Peripheral blood
- From:
Chinese Journal of Experimental and Clinical Virology
2017;31(5):446-449
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the changes of peripheral blood picture of CHB with Peg-IFN, and explored the relationship between the changes and decline of HBV DNA, clearance of HBsAg.
Methods:Patients with CHB treated with Peg-IFN α-2 a in the Second Division of Liver Disease in Beijing Ditan Hospital were monitored for blood routine examination and Liver function, kidney function, thyroid function of baseline and weeks 2, 4, 8, 12, 24, 36, 48, and weeks 12, 24, and 48 after the end of treatment for chronic hepatitis B, and HBV DNA, HBsAg.
Results:The decrease of peripheral blood cells began to occur at week 2 of treatment. For CHB with HBeAg negative patients, white blood cells, lymphocyte, neutrophils, hemoglobin and platelets significantly decreased at 2 weeks, while a minimum value occurred at 48 weeks. The recovery was obvious at the end of treatment (48 weeks), and reached pre-treatment levels at 48 weeks after the end of treatment. For CHB with HBeAg positive patients, white blood cells, neutrophils, hemoglobin and platelets significantly decreased at 2 weeks, while a minimum value was found at 36-48 weeks. The recovery was obvious at the end of treatment (48 weeks), and reached pre-treatment levels at 48weeks after the end of treatment. For patients with CHB, hemoglobin declined by more than13.64% at 36th week, which means that the patient would have a predictive significance for decrease of HBV DNA, and drops of more than 0.33% at 2nd week means that the patient would have a predictive significance for clearance of HBsAg.
Conclusions:During the treatment with interferon, the variation regularity of blood picture for predicting result have a certain effect, which may help predict and monitor the change of blood picture in clinical work.
